A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NCCLS / National Committee for Clinical Laboratory Standards

[Related PubMed/MEDLINE]
Total Number of Papers: 484
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NCCLS  (>> Co-occurring Abbreviation)
Long Form:   National Committee for Clinical Laboratory Standards
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 To study the profile of Candida isolates and antifungal susceptibility pattern of neonatal sepsis in a tertiary care hospital of North India. AFS, CLSI, NAC
2018 Ionic Liquid-Promoted Synthesis of Novel Chromone-Pyrimidine Coupled Derivatives, Antimicrobial Analysis, Enzyme Assay, Docking Study and Toxicity Study. ---
2017 In vitro antifungal activity of some traditional Persian medicinal plants on pathogenic fungi. MFC, MIC
2017 Severe Ocular Bacterial Infections: A Retrospective Study Over 13 Years. ---
2015 Epidemiologic and Drug Resistance Pattern of Vibrio cholerae O1 Biotype El Tor, Serotype Ogawa, in the 2011 Cholera Outbreak, in Alborz Province, Iran. ---
2015 Studies on the drug resistance profile of Enterococcus faecium distributed from poultry retailers to hospitals. MALDI-TOF, MCC, MEF, Q-D, qPCR, VRE
2014 Comparison of the mycobacterium growth indicator tube method and the method of proportion for drug susceptibility testing of mycobacterium tuberculosis. EMB, MDR-TB, MGIT, MOP, RIF, SM
2014 Role of aqueous extract of morinda citrifolia (Indian noni) ripe fruits in inhibiting dental caries-causing streptococcus mutans and streptococcus mitis. MIC
2013 Antibiotic susceptibility and genotype patterns of Pseudomonas aeruginosa from mechanical ventilation-associated pneumonia in intensive care units. AK, AZT, CAZ, CIP, IPM, MEM, MIC, MV, P. aeruginosa, PB, PIP, RAPD, VAP
10  2013 Bacteriological profile of neonatal septicemia and antibiotic susceptibility pattern of the isolates. ---
11  2013 Evaluation of the QBC Star centrifugal three-part differential haematology system. FBC, MCHC, POC, WCC
12  2013 [Change in drug resistance of Staphylococcus aureus]. MRSA, MSSA, SAU
13  2012 Antibiotic susceptibility of organisms causing urinary tract infection in patients presenting to a teaching hospital. UTI
14  2012 The pattern of bacterial isolates and drug sensitivities of infected ulcers in patients with leprosy in ALERT, Kuyera and Gambo hospitals, Ethiopia. ---
15  2011 Anti-microbial resistance profile of Citrobacter species in a tertiary care hospital of Southern India. ---
16  2011 Antibacterial activity of selected medicinal plants against multiple antibiotic resistant uropathogens: a study from Kolli Hills, Tamil Nadu, India. MAR
17  2011 Antibiotic susceptibility of methicillin-resistant and methicillin-susceptible coagulase-negative staphylococci isolated from bovine mastitis. CNS, MR, MS
18  2011 Antifungal activity of Aegle marmelos (L.) Correa (Rutaceae) leaf extract on dermatophytes. MFC, MIC
19  2011 Comparison of disc diffusion methods for the detection of extended-spectrum Beta lactamase-producing enterobacteriaceae. ESBLs, PCT
20  2011 In vitro susceptibility to different topical ophthalmic antibiotics of bacterial isolates from patients with conjunctivitis. ---
21  2011 Microbial keratitis in Waikato, New Zealand. ---
22  2011 Microbiological analysis of isolates in Kathmandu Medical College Teaching Hospital, Kathmandu, Nepal. UTIs
23  2011 Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion. ECOFF, EUCAST, ICS, MIC
24  2011 [Comparison and evaluation of testing results for two different coagulation analyzers]. APTT, FIB, PT, TT
25  2010 Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis. ---
26  2010 Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test. MIC
27  2010 Evaluation of amoxicillin plasma and tissue levels in pediatric patients undergoing tonsillectomy. MIC
28  2010 Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis. DST
29  2010 [Antibacterial activity determination of six kinds of natural herbs in yunnan on normal oral predominant]. MIC
30  2009 Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains causing childhood infection in Burkina Faso. ---
31  2009 Antimicrobial resistance pattern of Salmonella serotypes isolated from food items and personnel in Addis Ababa, Ethiopia. ---
32  2009 Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan. CLSI, MIC 50
33  2009 Fasting plasma glucose reference values among young Japanese women requiring 75g oral glucose tolerance tests. 75 g OGTT, FPG
34  2009 In vitro effects of glycyrrhetinic acid on the growth of clinical isolates of Candida albicans. 18-beta GA, RVVC
35  2009 Trends in antifungal susceptibility testing using CLSI reference and commercial methods. CLSI, QC
36  2009 [Comparison of the activities of silver nitrate with those of three antifungal agents against ocular pathogenic fungi in vitro]. MIC
37  2009 [Mutant prevention concentrations of antibacterial agents to ocular pathogenic bacteria]. CHL, CIP, LVF, MIC, MPC, MSW, NFL, OFL, TOB
38  2008 A comparison of PCR detection of mecA with oxacillin disk susceptibility testing in different media and sceptor automated system for both Staphylococcus aureus and coagulase-negative staphylococci isolates. CNS, MHA, MR, MSA, PCR
39  2008 Evaluation of a urinary metanephrines reagent kit: an automated approach. CV
40  2008 In vitro efficacy of diclofenac against Listeria monocytogenes. DC, MBC, MIC, NSAID, QSAR
41  2008 Low-level quinolone-resistance in multi-drug resistant typhoid. MDR, MICs
42  2008 Penicillin-resistant pneumococcus and risk of treatment failure in pneumonia. CLSI, MIC
43  2008 Prevalence of extended spectrum beta lactamase and AmpC beta lactamase producers among Escherichia coli isolates in a tertiary care hospital in Jaipur. E. coli, ESbetaL
44  2008 [Detection and analysis of antibiotic resistance of Salmonella from retail meats in some districts of Shaanxi province]. MDR
45  2008 [Fungal blood stream infection, its pathogen and antifungal susceptibility in cancer patients]. AST
46  2008 [Investigation of susceptibility testing methods for micafungin: comparison of two microdilution methods]. JSMM, MCFG
47  2007 Citrobacter infections in a tertiary care hospital in Northern India. ---
48  2007 Etiological agents of bacteremia in the early period after liver transplantation. HLAR, MDR, MRCNS, OLT
49  2007 Fusarium spp. as agents of onychomycosis in immunocompetent hosts. ---
50  2007 Modelling Staphylococcus aureus-induced septicemia using NMR. DMMP, MIC, RBCs
51  2007 Sweat testing practice in Swiss hospitals. CF
52  2007 [Analysis on variance of common pathogenic bacteria and drug resistance in children in Chengdu area from 2001 to 2006]. Hi, MRCNS, MRSA
53  2007 [Prevalence of resistance to metronidazole in Helicobacter pylori from children and induction of resistance in vitro]. H. pylori, MICs, MTZ
54  2007 [Pseudomonas aeruginosa: frequency of resistance to multiple drugs and cross-resistance between antimicrobials in Recife/PE]. P. aeruginosa
55  2007 [Sweat testing practices in German cystic fibrosis centres]. CF
56  2007 [The clinical and pathogenic characteristics of keratitis caused by Alternaria alternata]. ---
57  2007 [The development and in vitro experiment study of a bio-type root canal filling sealer using calcium phosphate cement]. A. naeslundii, CPC, F. nucleatum, P. anaerobius, P. endodpntalis, P. gingivalis
58  2006 Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. AMPH, EGCG, FLCZ, ITCZ, MCFG, MCZ
59  2006 Antimicrobial activities of the leaf extracts of two Moroccan Cistus L. species. MICs
60  2006 Antimicrobial resistance in Haemophilus influenzae isolated from the nasopharynx among Japanese children with acute otitis media. AMP, AOM, bla, CCL, CDN, CFD, CFPN, CPD, MICs, OME, PBP, PBP3, PCR
61  2006 Emerging vancomycin resistance in enterococci in India. MIC, PCR, VRE
62  2006 Epidemiological study of Candida infections in blood: susceptibilities of Candida spp. to antifungal agents, and clinical features associated with the candidemia. ---
63  2006 Estimation of bias between 2 analytical methods at clinically important ranges. ---
64  2006 Evaluation of four portable self-monitoring blood glucose meters. ADA, CLIA, SMBG
65  2006 In vitro activity of fluoroquinolones against common respiratory pathogens. MICs
66  2006 In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia. MICs
67  2006 In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase. CAZ, CF, CLV, CLX, CTX, ESBLs, IMP, MICs, OMPs, SDS-PAGE
68  2006 Modified double-disc test for detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae. ESBLs, MDDT
69  2006 Molecular epidemiology of clinical and carrier strains of methicillin resistant Staphylococcus aureus (MRSA) in the hospital settings of north India. AK, CF, MICs, MRCNS, MRSA, PFGE
70  2006 Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. ESBL, MDR
71  2006 Nasopharyngeal colonization with Streptococcus pneumoniae in children infected with human immunodeficiency virus. CDC
72  2006 Performance evaluation of the immature granulocyte parameter on the Sysmex XE-2100 automated hematology analyzer. IG, SAMC
73  2006 Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi. DD, MIC, NA, S. Typhi
74  2006 Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest. AmB, MICs
75  2006 [Studies on the correlation of the method currently used by the Japanese Society for Medical Mycology and its modified method with the NCCLS M27-A2 microdilution method for azole susceptibility testing of Candida species]. JSMM
76  2006 [The concentrations of fluoroquinolones in prevention of Staphylococcus epidermidis from mutant in ocular surface]. MICs, MPC
77  2006 [The rate of isolation of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and resistance to antibiotics]. ESBLs, ICUs, K. pneumoniae, KUMH
78  2005 Accuracy of current oxacillin sensitivity tests routinely used in hospitals in Western Saudi Arabia. MRSA, PCR, S. aureus
79  2005 Alarming trend of clarithromycin-resistant Streptococcus pyogenes in Japan (1998-2002). MICs
80  2005 An epidemiological study of the susceptibility and frequency of multiple-drug-resistant strains of Pseudomonas aeruginosa isolated at medical institutes nationwide in Japan. MIC
81  2005 Antibiogram pattern of isolates from UTI cases in Eastern part of Nepal. UTI
82  2005 Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). NAUTICA, SMX/TMP
83  2005 Antimicrobial susceptibility in intensive care units: MYSTIC Program Brazil 2002. ---
84  2005 Antimicrobial susceptibility of Gram-negative bacteria in Brazilian hospitals: the MYSTIC Program Brazil 2003. ---
85  2005 Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002). NF-GNB
86  2005 Assessment of accuracy of disk diffusion tests for the determination of antimicrobial susceptibility of common bovine mastitis pathogens: a novel approach. ---
87  2005 Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria. ESBL
88  2005 Comparison of antibiotic susceptibility tests, plasmid profiles and restriction enzyme analysis of plasmid DNA of methicillin susceptible and resistant-Staphylococcus aureus strains isolated from intensive care units. ICU's, KSA, MSSA, REAP, S. aureus
89  2005 Contamination of patients' files in intensive care units: an indication of strict handwashing after entering case notes. HCWs, ICU, MRSA
90  2005 Detection of metallo betalactamase producing Pseudomonas aeruginosa in hospitalized patients. EDTA, MBL, MIC
91  2005 Enterococci from Tolminc cheese: population structure, antibiotic susceptibility and incidence of virulence determinants. CATC
92  2005 Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan. MIC
93  2005 Evaluation of the ABX Pentra 400: a newly available clinical chemistry analyser. CV
94  2005 Evaluation of the anti-Trichophyton activity of a prodigiosin analogue produced by gamma-proteobacterium, using stratum corneum epidermis of the Yucatan micropig. MIC, PGs, SCE
95  2005 In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. MIC
96  2005 In vitro antifungal activity of ZJ-522, a new triazole restructured from fluconazole and butenafine, against clinically important fungi in comparison with fluconazole and butenafine. ---
97  2005 In vitro susceptibility of oral Candida to seven antifungal agents. ---
98  2005 Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. AmB, CAS, IA, ITC, MEC, MFC, VRC
99  2005 Isolate removal methods and methicillin-resistant Staphylococcus aureus surveillance. ---
100  2005 Measurement of intracellular vitamin C levels in human lymphocytes by reverse phase high performance liquid chromatography (HPLC). CV, HPLC